Norman Swan
speaker
10,274 appearances
109 recordings
1 series
first heard Mar 2020
last heard 11 Aug
Norman Swan’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Aug 2026 with 1.
Appearances
And it would stop the virus replicating and presumably stop infection of others, which in fact is what happens with HIV.
When you get the HIV viral load down very, very low, you actually can prevent transmission.
Yeah.
So this, even if they accelerate, they will get a lot of patients, unfortunately, because there's still a lot of COVID around.
So it's going to be quite easy to do.
a phase three trial if it's safe in phase one.
So phase one is gross safety.
So they will be able to recruit a lot of patients quite quickly in the same way as they were for the vaccines.
So it'll be a great thing because we are short of antiviral drugs.
So it'll be a fantastic thing to get.
And it's particularly in a world where the world is not going to be vaccinated to a significant extent anytime soon.
So a treatment is still going to be incredibly useful.
Who knows?
I mean, I think they're talking about moving into phase three trials quite quickly if the phase one is OK.
But you're probably not going to see this being ready for approval till next year.
So yeah, this is a really interesting study.
First one is looking at women who are pregnant and what happens to their pregnancy and to the women when they get infected with COVID-19.
It's a study that was involved 43 institutions, 18 countries.
total of 700 pregnant women.
So it's not a huge sample, but it's big enough.
Showing 581–600 of 10,274 · page 30 of 514
← Previous
Next →